{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "25",
                "@timestamp": "2022-07-25T04:11:42.000042-04:00",
                "@year": "2022",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "04"
            }
        },
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "organization": [
                                {"$": "Department of Pharmacy Practice"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"},
                                {"$": "Bangkok"},
                                {"$": "College of Pharmacotherapy of Thailand"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113044315"
                            },
                            "@affiliation-instance-id": "2017445751-f9f903f0e8b9e875539b15c1f6ce71ad",
                            "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, College of Pharmacotherapy of Thailand, Thailand.",
                            "@dptid": "113044315"
                        },
                        "author": [
                            {
                                "ce:given-name": "Sirinoot",
                                "preferred-name": {
                                    "ce:given-name": "Sirinoot",
                                    "ce:initials": "S.",
                                    "ce:surname": "Palapinyo",
                                    "ce:indexed-name": "Palapinyo S."
                                },
                                "@author-instance-id": "2017445751-06044226182f3b034a995cabb2a4ebfd",
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Palapinyo",
                                "@auid": "37031882400",
                                "ce:indexed-name": "Palapinyo S."
                            },
                            {
                                "ce:given-name": "Nutthada",
                                "preferred-name": {
                                    "ce:given-name": "Nutthada",
                                    "ce:initials": "N.",
                                    "ce:surname": "Areepium",
                                    "ce:indexed-name": "Areepium N."
                                },
                                "@author-instance-id": "2017445751-5013784a799813e044dc4c950fb5099b",
                                "@seq": "4",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Areepium",
                                "@auid": "13610558100",
                                "ce:indexed-name": "Areepium N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Allergy and Clinical Immunology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "Bangkok"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183427"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2017445751-206b94d5e6208120c531f76b779c54bd",
                            "ce:source-text": "Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.",
                            "@dptid": "103183427"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jettanong",
                                "preferred-name": {
                                    "ce:given-name": "Jettanong",
                                    "ce:initials": "J.",
                                    "ce:surname": "Klaewsongkram",
                                    "ce:indexed-name": "Klaewsongkram J."
                                },
                                "@author-instance-id": "2017445751-725e90a3f59d7e7a1045f365d0f9479e",
                                "@seq": "2",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Klaewsongkram",
                                "@auid": "6508090526",
                                "ce:indexed-name": "Klaewsongkram J."
                            },
                            {
                                "ce:given-name": "Virote",
                                "preferred-name": {
                                    "ce:given-name": "Virote",
                                    "ce:initials": "V.",
                                    "ce:surname": "Sriuranpong",
                                    "ce:indexed-name": "Sriuranpong V."
                                },
                                "@author-instance-id": "2017445751-feeef944003fa04679c86ce72a0a680e",
                                "@seq": "3",
                                "ce:initials": "V.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sriuranpong",
                                "@auid": "6603599644",
                                "ce:indexed-name": "Sriuranpong V."
                            }
                        ]
                    }
                ],
                "citation-title": "Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study",
                "abstracts": "Â© 2022, Grupo de Investigacion en Atencion Farmaceutica. All rights reserved.Background: Oxaliplatin is a third-generation platinum compound that has efficacy against colorectal cancer. Hypersensitivity reactions during oxaliplatin infusion are a key problem during its use, with the varying incidences and deficiencies of clearly identified risk factors. Objective: To determine the incidence, severity and risk factors of oxaliplatin-related hypersensitivity reaction (HSR). Method: This retrospective study investigated 245 colorectal cancer patients (1,690 treatment cycles) receiving care at King Chulalongkorn Memorial Hospital, Thai Red Cross society between January 1, 2015 and December 31, 2019. The patients\u2019 demographic data, laboratory data and clinical features suggesting hypersensitivity reactions to oxaliplatin were reviewed. The Fisher\u2019s Exact test and unpaired t-test were used to determine the differences among patients with and without oxaliplatin HSR. The potential risk factors for oxaliplatin HSR were analyzed for statistical significance by logistic regression. Results: A total of 245 colorectal cancer patients (1,690 treatment cycles) were included in this study. The incidence of oxaliplatin HSR was 37.96%, according to the US National Cancer Institute (NCI)-Common Terminology Criteria for Adverse Events (NTCAE) version 5.0, grade 1, grade 2 and higher grades were 27.35% (67 patients), 6.53% (16 patients) and 4.08% (10 patients), respectively. The proportion of male patients and patients with a history of prior exposure to platinum-based chemotherapy were statistically higher in the HSR group. The eosinophil count and serum creatinine level were also significantly greater in the HSR group. On the contrary, the total lymphocyte count and serum albumin level were significantly lower in the HSR group. The multivariate logistic regression found 5 risk factors with a significant difference. Male gender, prior exposure to platinum-based chemotherapy and elevated eosinophil count were associated with increased risk of oxaliplatin HSR, whereas elevated monocyte count and elevated serum albumin were protective factors for the development of oxaliplatin HSR. Conclusion: Colorectal cancer patients treated with an oxaliplatin-based regimen with male gender, prior exposure to platinum-based chemotherapy and elevated eosinophil count have a greater risk of oxaliplatin related hypersensitivity reactions.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "organization": [
                            {"$": "Department of Pharmacy Practice"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"},
                            {"$": "Bangkok"},
                            {"$": "College of Pharmacotherapy of Thailand"}
                        ],
                        "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, College of Pharmacotherapy of Thailand, Thailand."
                    },
                    "person": {
                        "ce:given-name": "Nutthada",
                        "ce:initials": "N.",
                        "ce:surname": "Areepium",
                        "ce:indexed-name": "Areepium N."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Colorectal cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Hypersensitivity reactions",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Oxaliplatin",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Risk factors",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.pharmacypractice.org/index.php/pp/article/download/2635/987",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Pharmacy Practice",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "20",
                        "@issue": "2"
                    }},
                    "@type": "j",
                    "sourcetitle": "Pharmacy Practice",
                    "publicationdate": {
                        "month": "04",
                        "year": "2022",
                        "date-text": "Apr-Jun 2022",
                        "day": "01"
                    },
                    "codencode": "PPHRG",
                    "sourcetitle-abbrev": "Pharm. Pract.",
                    "@country": "esp",
                    "issn": [
                        {
                            "$": "18863655",
                            "@type": "electronic"
                        },
                        {
                            "$": "1885642X",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Grupo de Investigacion en Atencion Farmaceutica"},
                    "article-number": "2635",
                    "@srcid": "4700152701"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3611"},
                                {"$": "3003"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "HEAL"},
                                {"$": "PHAR"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "9000-86-6"},
                                    {"$": "9014-30-6"}
                                ],
                                "enzyme-commission-number": "EC 2.6.1.2",
                                "chemical-name": "alanine aminotransferase"
                            },
                            {
                                "cas-registry-number": "9001-78-9",
                                "enzyme-commission-number": "EC 3.1.3.1",
                                "chemical-name": "alkaline phosphatase"
                            },
                            {
                                "cas-registry-number": "9000-97-9",
                                "enzyme-commission-number": "EC 2.6.1.1",
                                "chemical-name": "aspartate aminotransferase"
                            },
                            {
                                "cas-registry-number": "154361-50-9",
                                "chemical-name": "capecitabine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "19230-81-0"},
                                    {"$": "60-27-5"}
                                ],
                                "chemical-name": "creatinine"
                            },
                            {
                                "cas-registry-number": "50-02-2",
                                "chemical-name": "dexamethasone"
                            },
                            {
                                "cas-registry-number": "51-21-8",
                                "chemical-name": "fluorouracil"
                            },
                            {
                                "cas-registry-number": "58-05-9",
                                "chemical-name": "folinic acid"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "103639-04-9"},
                                    {"$": "116002-70-1"},
                                    {"$": "99614-01-4"}
                                ],
                                "chemical-name": "ondansetron"
                            },
                            {
                                "cas-registry-number": "61825-94-3",
                                "chemical-name": "oxaliplatin"
                            },
                            {
                                "cas-registry-number": "7440-06-4",
                                "chemical-name": "platinum"
                            },
                            {
                                "cas-registry-number": "9048-46-8",
                                "chemical-name": "serum albumin"
                            }
                        ]
                    }}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "22",
                    "@timestamp": "BST 03:08:50",
                    "@year": "2022",
                    "@month": "07"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2017445751",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "941561803",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220639670",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "20222151788",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20222426179",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20229009998812",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85133959611",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85133959611",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.18549/PharmPract.2022.2.2635"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "31",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89-103. https://doi.org/10.5114/pg.2018.81072",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.5114/pg.2018.81072",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5114/pg.2018.81072",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85068484180",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "89",
                                    "@last": "103"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Rawla",
                                    "ce:indexed-name": "Rawla P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Sunkara",
                                    "ce:indexed-name": "Sunkara T"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Barsouk",
                                    "ce:indexed-name": "Barsouk A."
                                }
                            ]},
                            "ref-sourcetitle": "Prz Gastroenterol"
                        },
                        "ce:source-text": "Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89-103. https://doi.org/10.5114/pg.2018.81072"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2. 2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(3):329-59. https://doi.org/10.6004/jnccn.2021.0012",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.6004/jnccn.2021.0012",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Colon Cancer, Version 2. 2021, NCCN Clinical Practice Guidelines in Oncology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.6004/jnccn.2021.0012",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85101218872",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "329",
                                    "@last": "359"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AB",
                                        "@_fa": "true",
                                        "ce:surname": "Benson",
                                        "ce:indexed-name": "Benson AB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AP",
                                        "@_fa": "true",
                                        "ce:surname": "Venook",
                                        "ce:indexed-name": "Venook AP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MM",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Hawary",
                                        "ce:indexed-name": "Al-Hawary MM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Compr Canc Netw"
                        },
                        "ce:source-text": "Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2. 2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(3):329-59. https://doi.org/10.6004/jnccn.2021.0012"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lohsiriwat V, Chaisomboon N, Pattana-Arun J. Current Colorectal Cancer in Thailand. Ann Coloproctol. 2020;36(2):78-82. https://doi.org/10.3393/ac.2020.01.07",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.3393/ac.2020.01.07",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Current Colorectal Cancer in Thailand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3393/ac.2020.01.07",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85084345129",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "78",
                                    "@last": "82"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "V",
                                    "@_fa": "true",
                                    "ce:surname": "Lohsiriwat",
                                    "ce:indexed-name": "Lohsiriwat V"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Chaisomboon",
                                    "ce:indexed-name": "Chaisomboon N"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Pattana-Arun",
                                    "ce:indexed-name": "Pattana-Arun J."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Coloproctol"
                        },
                        "ce:source-text": "Lohsiriwat V, Chaisomboon N, Pattana-Arun J. Current Colorectal Cancer in Thailand. Ann Coloproctol. 2020;36(2):78-82. https://doi.org/10.3393/ac.2020.01.07"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Huang W-K, Hsu H-C, Chang S-H, et al. Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis. Front Pharmacol. 2021;12:693009. https://doi.org/10.3389/fphar.2021.693009",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.3389/fphar.2021.693009",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2021.693009",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85110360599",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "693009"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W-K",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang W-K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H-C",
                                        "@_fa": "true",
                                        "ce:surname": "Hsu",
                                        "ce:indexed-name": "Hsu H-C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S-H",
                                        "@_fa": "true",
                                        "ce:surname": "Chang",
                                        "ce:indexed-name": "Chang S-H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Huang W-K, Hsu H-C, Chang S-H, et al. Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis. Front Pharmacol. 2021;12:693009. https://doi.org/10.3389/fphar.2021.693009"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29(1):44-70. https://doi.org/10.1093/annonc/mdx738",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1093/annonc/mdx738",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdx738",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041205697",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "44",
                                    "@last": "70"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Arnold",
                                        "ce:indexed-name": "Arnold D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Taniguchi",
                                        "ce:indexed-name": "Taniguchi H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29(1):44-70. https://doi.org/10.1093/annonc/mdx738"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Devanabanda B, Kasi A. Oxaliplatin. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC.; Dec 28, 2021.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Oxaliplatin"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85133953970",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Treasure Island (FL): StatPearls Publishing LLC.; Dec 28",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Devanabanda",
                                    "ce:indexed-name": "Devanabanda B"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kasi",
                                    "ce:indexed-name": "Kasi A."
                                }
                            ]},
                            "ref-sourcetitle": "StatPearls"
                        },
                        "ce:source-text": "Devanabanda B, Kasi A. Oxaliplatin. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC.; Dec 28, 2021."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Zhao L, Liu R, Zhang Z, et al. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials. Colorectal dis. 2016;18(8):763-72. https://doi.org/10.1111/codi.13381",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1111/codi.13381",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/codi.13381",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84980037402",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "763",
                                    "@last": "772"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Colorectal dis"
                        },
                        "ce:source-text": "Zhao L, Liu R, Zhang Z, et al. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials. Colorectal dis. 2016;18(8):763-72. https://doi.org/10.1111/codi.13381"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Benson AB, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-69. https://doi.org/10.6004/jnccn.2018.0021",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.6004/jnccn.2018.0021",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "NCCN Guidelines Insights: Colon Cancer, Version 2.2018"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.6004/jnccn.2018.0021",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85045662724",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "359",
                                    "@last": "369"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AB",
                                        "@_fa": "true",
                                        "ce:surname": "Benson",
                                        "ce:indexed-name": "Benson AB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AP",
                                        "@_fa": "true",
                                        "ce:surname": "Venook",
                                        "ce:indexed-name": "Venook AP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MM",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Hawary",
                                        "ce:indexed-name": "Al-Hawary MM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Compr Canc Netw"
                        },
                        "ce:source-text": "Benson AB, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-69. https://doi.org/10.6004/jnccn.2018.0021"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Jeon H-J, Woo J-H, Lee H-Y, et al. Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer. J Korean Soc Coloproctol. 2011;27(3):140-6. https://doi.org/10.3393/jksc.2011.27.3.140",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.3393/jksc.2011.27.3.140",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3393/jksc.2011.27.3.140",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "80051491325",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "140",
                                    "@last": "146"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H-J",
                                        "@_fa": "true",
                                        "ce:surname": "Jeon",
                                        "ce:indexed-name": "Jeon H-J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J-H",
                                        "@_fa": "true",
                                        "ce:surname": "Woo",
                                        "ce:indexed-name": "Woo J-H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H-Y",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee H-Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Korean Soc Coloproctol"
                        },
                        "ce:source-text": "Jeon H-J, Woo J-H, Lee H-Y, et al. Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer. J Korean Soc Coloproctol. 2011;27(3):140-6. https://doi.org/10.3393/jksc.2011.27.3.140"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lee C, Gianos M, Klaustermeyer WB. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol. 2017;119(5):422-428.e2. https://doi.org/10.1016/j.anai.2017.08.009",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1016/j.anai.2017.08.009",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.anai.2017.08.009",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85133968433",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "119",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "422",
                                    "@last": "428"
                                }
                            },
                            "ref-text": "e2",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Gianos",
                                    "ce:indexed-name": "Gianos M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "WB.",
                                    "@_fa": "true",
                                    "ce:surname": "Klaustermeyer",
                                    "ce:indexed-name": "Klaustermeyer WB."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Allergy Asthma Immunol"
                        },
                        "ce:source-text": "Lee C, Gianos M, Klaustermeyer WB. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol. 2017;119(5):422-428.e2. https://doi.org/10.1016/j.anai.2017.08.009"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Otani IM, Wong J, Banerji A. Platinum Chemotherapy Hypersensitivity: Prevalence and Management. Immunol Allergy Clin North Am. 2017;37(4):663-77. https://doi.org/10.1016/j.iac.2017.06.003",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1016/j.iac.2017.06.003",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Platinum Chemotherapy Hypersensitivity: Prevalence and Management"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.iac.2017.06.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85027683603",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "663",
                                    "@last": "677"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "IM",
                                    "@_fa": "true",
                                    "ce:surname": "Otani",
                                    "ce:indexed-name": "Otani IM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Wong",
                                    "ce:indexed-name": "Wong J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Banerji",
                                    "ce:indexed-name": "Banerji A."
                                }
                            ]},
                            "ref-sourcetitle": "Immunol Allergy Clin North Am"
                        },
                        "ce:source-text": "Otani IM, Wong J, Banerji A. Platinum Chemotherapy Hypersensitivity: Prevalence and Management. Immunol Allergy Clin North Am. 2017;37(4):663-77. https://doi.org/10.1016/j.iac.2017.06.003"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yamauchi H, Goto T, Takayoshi K, et al. A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin. Eur J Cancer Care (Engl). 2015;24(1):111-6. https://doi.org/10.1111/ecc.12156",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1111/ecc.12156",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/ecc.12156",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84919863230",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "111",
                                    "@last": "116"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Yamauchi",
                                        "ce:indexed-name": "Yamauchi H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Goto",
                                        "ce:indexed-name": "Goto T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Takayoshi",
                                        "ce:indexed-name": "Takayoshi K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer Care (Engl)"
                        },
                        "ce:source-text": "Yamauchi H, Goto T, Takayoshi K, et al. A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin. Eur J Cancer Care (Engl). 2015;24(1):111-6. https://doi.org/10.1111/ecc.12156"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ohta H, Hayashi T, Murai S, et al. Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer. Cancer Chemother Pharmacol. 2017;79(5):1021-9. https://doi.org/10.1007/s00280-017-3294-9",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1007/s00280-017-3294-9",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00280-017-3294-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85017120285",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "79",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1021",
                                    "@last": "1029"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Ohta",
                                        "ce:indexed-name": "Ohta H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Hayashi",
                                        "ce:indexed-name": "Hayashi T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Murai",
                                        "ce:indexed-name": "Murai S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother Pharmacol"
                        },
                        "ce:source-text": "Ohta H, Hayashi T, Murai S, et al. Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer. Cancer Chemother Pharmacol. 2017;79(5):1021-9. https://doi.org/10.1007/s00280-017-3294-9"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kim MY, Kang SY, Lee SY, et al. Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans. Asian Pac J Cancer Prev. 2012;13(4):1209-15. https://doi.org/10.7314/apjcp.2012.13.4.1209",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.7314/apjcp.2012.13.4.1209",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.7314/apjcp.2012.13.4.1209",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84873027526",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1209",
                                    "@last": "1215"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MY",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim MY"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SY",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang SY"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SY",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee SY"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Asian Pac J Cancer Prev"
                        },
                        "ce:source-text": "Kim MY, Kang SY, Lee SY, et al. Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans. Asian Pac J Cancer Prev. 2012;13(4):1209-15. https://doi.org/10.7314/apjcp.2012.13.4.1209"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yu Z, Huang R, Zhao L, et al. Safety profile of oxaliplatin in 3,687 patients with cancer in China: A post-marketing surveillance study. Front Oncol. 2021;11:757196. https://doi.org/10.3389/fonc.2021.757196",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.3389/fonc.2021.757196",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Safety profile of oxaliplatin in 3,687 patients with cancer in China: A post-marketing surveillance study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fonc.2021.757196",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85118641445",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "757196"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Yu",
                                        "ce:indexed-name": "Yu Z"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Oncol"
                        },
                        "ce:source-text": "Yu Z, Huang R, Zhao L, et al. Safety profile of oxaliplatin in 3,687 patients with cancer in China: A post-marketing surveillance study. Front Oncol. 2021;11:757196. https://doi.org/10.3389/fonc.2021.757196"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Mori Y, Nishimura T, Kitano T, et al. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX. Oncology. 2010;79(1-2):136-43. https://doi.org/10.1159/000320613",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1159/000320613",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000320613",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "78649797013",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "79",
                                    "@issue": "1-2"
                                },
                                "pagerange": {
                                    "@first": "136",
                                    "@last": "143"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Mori",
                                        "ce:indexed-name": "Mori Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Nishimura",
                                        "ce:indexed-name": "Nishimura T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Kitano",
                                        "ce:indexed-name": "Kitano T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncology"
                        },
                        "ce:source-text": "Mori Y, Nishimura T, Kitano T, et al. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX. Oncology. 2010;79(1-2):136-43. https://doi.org/10.1159/000320613"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kim BH, Bradley T, Tai J, et al. Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review. Oncology. 2009;76(4):231-8. https://doi.org/10.1159/000205263",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1159/000205263",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000205263",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "60749124656",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "76",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "231",
                                    "@last": "238"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BH",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim BH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Bradley",
                                        "ce:indexed-name": "Bradley T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Tai",
                                        "ce:indexed-name": "Tai J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncology"
                        },
                        "ce:source-text": "Kim BH, Bradley T, Tai J, et al. Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review. Oncology. 2009;76(4):231-8. https://doi.org/10.1159/000205263"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Seki K, Senzaki K, Tsuduki Y, et al. Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer. Int J Med Sci. 2011;8(3):210-5. https://doi.org/10.7150/ijms.8.210",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.7150/ijms.8.210",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.7150/ijms.8.210",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "79955544205",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "210",
                                    "@last": "215"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Seki",
                                        "ce:indexed-name": "Seki K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Senzaki",
                                        "ce:indexed-name": "Senzaki K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Tsuduki",
                                        "ce:indexed-name": "Tsuduki Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Med Sci"
                        },
                        "ce:source-text": "Seki K, Senzaki K, Tsuduki Y, et al. Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer. Int J Med Sci. 2011;8(3):210-5. https://doi.org/10.7150/ijms.8.210"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Parel M, Ranchon F, Nosbaum A, et al. Hypersensitivity to oxaliplatin: clinical features and risk factors. BMC Pharmacol Toxicol. 2014;15:1. https://doi.org/10.1186/2050-6511-15-1",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1186/2050-6511-15-1",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Hypersensitivity to oxaliplatin: clinical features and risk factors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/2050-6511-15-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84905560844",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {"@first": "1"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Parel",
                                        "ce:indexed-name": "Parel M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Ranchon",
                                        "ce:indexed-name": "Ranchon F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Nosbaum",
                                        "ce:indexed-name": "Nosbaum A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Pharmacol Toxicol"
                        },
                        "ce:source-text": "Parel M, Ranchon F, Nosbaum A, et al. Hypersensitivity to oxaliplatin: clinical features and risk factors. BMC Pharmacol Toxicol. 2014;15:1. https://doi.org/10.1186/2050-6511-15-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27, 2017. US Department of Health and Human Services NIoH, National Cancer Institute. 2017.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "refd-itemidlist": {"itemid": {
                                "$": "12744281454",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Published: November 27, US Department of Health and Human Services NIoH, National Cancer Institute. 2017",
                            "ref-sourcetitle": "Common Terminology Criteria for Adverse Events (CTCAE) Version 5"
                        },
                        "ce:source-text": "Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27, 2017. US Department of Health and Human Services NIoH, National Cancer Institute. 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Azam F, Latif MF, Farooq A, et al. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Rep Oncol. 2019;12(3):728-36. https://doi.org/10.1159/000503095",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1159/000503095",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000503095",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85072784957",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "728",
                                    "@last": "736"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Azam",
                                        "ce:indexed-name": "Azam F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Latif",
                                        "ce:indexed-name": "Latif MF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Farooq",
                                        "ce:indexed-name": "Farooq A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Case Rep Oncol"
                        },
                        "ce:source-text": "Azam F, Latif MF, Farooq A, et al. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Rep Oncol. 2019;12(3):728-36. https://doi.org/10.1159/000503095"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ichikawa Y, Goto A, Hirokawa S, et al. Allergic reactions to oxaliplatin in a single institute in Japan. Jpn J Clin Oncol. 2009;39(9):616-20. https://doi.org/10.1093/jjco/hyp070",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1093/jjco/hyp070",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Allergic reactions to oxaliplatin in a single institute in Japan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jjco/hyp070",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "69949148765",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "39",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "616",
                                    "@last": "620"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Ichikawa",
                                        "ce:indexed-name": "Ichikawa Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Goto",
                                        "ce:indexed-name": "Goto A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Hirokawa",
                                        "ce:indexed-name": "Hirokawa S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Jpn J Clin Oncol"
                        },
                        "ce:source-text": "Ichikawa Y, Goto A, Hirokawa S, et al. Allergic reactions to oxaliplatin in a single institute in Japan. Jpn J Clin Oncol. 2009;39(9):616-20. https://doi.org/10.1093/jjco/hyp070"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "AndrÃ© T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon canceEngl J Med. 2004;350:2343-51.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon canceEngl"},
                            "refd-itemidlist": {"itemid": {
                                "$": "2542615200",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "350"},
                                "pagerange": {
                                    "@first": "2343",
                                    "@last": "2351"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "AndrÃ©",
                                        "ce:indexed-name": "Andre T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Boni",
                                        "ce:indexed-name": "Boni C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Mounedji-Boudiaf",
                                        "ce:indexed-name": "Mounedji-Boudiaf L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Med"
                        },
                        "ce:source-text": "AndrÃ© T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon canceEngl J Med. 2004;350:2343-51."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol. 2006;6:476-81.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Desensitization for drug allergy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33750838597",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "476",
                                    "@last": "481"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "ce:surname": "Castells",
                                "ce:indexed-name": "Castells M."
                            }]},
                            "ref-sourcetitle": "Curr Opin Allergy Clin Immunol"
                        },
                        "ce:source-text": "Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol. 2006;6:476-81."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Makrilia N, Syrigou E, Kaklamanos I, et al. Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review. Met Based Drugs. 2010;2010:207084. https://doi.org/10.1155/2010/207084",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1155/2010/207084",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1155/2010/207084",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "77957927866",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2010"},
                                "pagerange": {"@first": "207084"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Makrilia",
                                        "ce:indexed-name": "Makrilia N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Syrigou",
                                        "ce:indexed-name": "Syrigou E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Kaklamanos",
                                        "ce:indexed-name": "Kaklamanos I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Met Based Drugs"
                        },
                        "ce:source-text": "Makrilia N, Syrigou E, Kaklamanos I, et al. Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review. Met Based Drugs. 2010;2010:207084. https://doi.org/10.1155/2010/207084"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Okayama T, Ishikawa T, Sugatani K, et al. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging thEfficacy of a Desensitization Protocol. Clin Ther. 2015;37(6):1259-69. https://doi.org/10.1016/j.clinthera.2015.03.012",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1016/j.clinthera.2015.03.012",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging thEfficacy of a Desensitization Protocol"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.clinthera.2015.03.012",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84931564212",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1259",
                                    "@last": "1269"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Okayama",
                                        "ce:indexed-name": "Okayama T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Ishikawa",
                                        "ce:indexed-name": "Ishikawa T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Sugatani",
                                        "ce:indexed-name": "Sugatani K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Ther"
                        },
                        "ce:source-text": "Okayama T, Ishikawa T, Sugatani K, et al. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging thEfficacy of a Desensitization Protocol. Clin Ther. 2015;37(6):1259-69. https://doi.org/10.1016/j.clinthera.2015.03.012"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kuruvilla M, Khan DA. Eosinophilic Drug Allergy. Clin Rev Allergy Immunol. 2016;50:228-39.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Eosinophilic Drug Allergy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84929889125",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "228",
                                    "@last": "239"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Kuruvilla",
                                    "ce:indexed-name": "Kuruvilla M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DA.",
                                    "@_fa": "true",
                                    "ce:surname": "Khan",
                                    "ce:indexed-name": "Khan DA."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Rev Allergy Immunol"
                        },
                        "ce:source-text": "Kuruvilla M, Khan DA. Eosinophilic Drug Allergy. Clin Rev Allergy Immunol. 2016;50:228-39."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Shibata Y, Ariyama H, Baba E, et al. Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan. Int J CliOncol. 2009;14:397-401.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan"},
                            "refd-itemidlist": {"itemid": {
                                "$": "70350508569",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "397",
                                    "@last": "401"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Shibata",
                                        "ce:indexed-name": "Shibata Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Ariyama",
                                        "ce:indexed-name": "Ariyama H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Baba",
                                        "ce:indexed-name": "Baba E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J CliOncol"
                        },
                        "ce:source-text": "Shibata Y, Ariyama H, Baba E, et al. Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan. Int J CliOncol. 2009;14:397-401."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Bourke CD, Berkley JA, Prendergast AJ. Immune Dysfunction as a Cause and Consequence of Malnutrition. Trends Immuno2016;37(6):386-98. https://doi.org/10.1016/j.it.2016.04.003",
                        "@id": "29",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1016/j.it.2016.04.003",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Immune Dysfunction as a Cause and Consequence of Malnutrition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.it.2016.04.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84969872395",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "386",
                                    "@last": "398"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CD",
                                    "@_fa": "true",
                                    "ce:surname": "Bourke",
                                    "ce:indexed-name": "Bourke CD"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Berkley",
                                    "ce:indexed-name": "Berkley JA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Prendergast",
                                    "ce:indexed-name": "Prendergast AJ."
                                }
                            ]},
                            "ref-sourcetitle": "Trends Immuno2016"
                        },
                        "ce:source-text": "Bourke CD, Berkley JA, Prendergast AJ. Immune Dysfunction as a Cause and Consequence of Malnutrition. Trends Immuno2016;37(6):386-98. https://doi.org/10.1016/j.it.2016.04.003"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nut2019;43(2):181-93. https://doi.org/10.1002/jpen.1451",
                        "@id": "30",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1002/jpen.1451",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Hypoalbuminemia: Pathogenesis and Clinical Significance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/jpen.1451",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85054545778",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "43",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "181",
                                    "@last": "193"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "PB",
                                    "@_fa": "true",
                                    "ce:surname": "Soeters",
                                    "ce:indexed-name": "Soeters PB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "RR",
                                    "@_fa": "true",
                                    "ce:surname": "Wolfe",
                                    "ce:indexed-name": "Wolfe RR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Shenkin",
                                    "ce:indexed-name": "Shenkin A."
                                }
                            ]},
                            "ref-sourcetitle": "JPEN J Parenter Enteral Nut2019"
                        },
                        "ce:source-text": "Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nut2019;43(2):181-93. https://doi.org/10.1002/jpen.1451"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Nishihara M, Nishikura K, Morikawa N, et al. Factors Influencing the Appearance of Oxaliplatin-Induced Allergy. B Biol Pharm Bull. 2017;40(12):2105-9. https://doi.org/10.1248/bpb.b17-00400",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1248/bpb.b17-00400",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Factors Influencing the Appearance of Oxaliplatin-Induced Allergy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1248/bpb.b17-00400",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85035787323",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2105",
                                    "@last": "2109"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Nishihara",
                                        "ce:indexed-name": "Nishihara M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Nishikura",
                                        "ce:indexed-name": "Nishikura K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Morikawa",
                                        "ce:indexed-name": "Morikawa N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "B Biol Pharm Bull"
                        },
                        "ce:source-text": "Nishihara M, Nishikura K, Morikawa N, et al. Factors Influencing the Appearance of Oxaliplatin-Induced Allergy. B Biol Pharm Bull. 2017;40(12):2105-9. https://doi.org/10.1248/bpb.b17-00400"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "prism:issueIdentifier": "2",
        "eid": "2-s2.0-85133959611",
        "dc:description": "Background: Oxaliplatin is a third-generation platinum compound that has efficacy against colorectal cancer. Hypersensitivity reactions during oxaliplatin infusion are a key problem during its use, with the varying incidences and deficiencies of clearly identified risk factors. Objective: To determine the incidence, severity and risk factors of oxaliplatin-related hypersensitivity reaction (HSR). Method: This retrospective study investigated 245 colorectal cancer patients (1,690 treatment cycles) receiving care at King Chulalongkorn Memorial Hospital, Thai Red Cross society between January 1, 2015 and December 31, 2019. The patients\u2019 demographic data, laboratory data and clinical features suggesting hypersensitivity reactions to oxaliplatin were reviewed. The Fisher\u2019s Exact test and unpaired t-test were used to determine the differences among patients with and without oxaliplatin HSR. The potential risk factors for oxaliplatin HSR were analyzed for statistical significance by logistic regression. Results: A total of 245 colorectal cancer patients (1,690 treatment cycles) were included in this study. The incidence of oxaliplatin HSR was 37.96%, according to the US National Cancer Institute (NCI)-Common Terminology Criteria for Adverse Events (NTCAE) version 5.0, grade 1, grade 2 and higher grades were 27.35% (67 patients), 6.53% (16 patients) and 4.08% (10 patients), respectively. The proportion of male patients and patients with a history of prior exposure to platinum-based chemotherapy were statistically higher in the HSR group. The eosinophil count and serum creatinine level were also significantly greater in the HSR group. On the contrary, the total lymphocyte count and serum albumin level were significantly lower in the HSR group. The multivariate logistic regression found 5 risk factors with a significant difference. Male gender, prior exposure to platinum-based chemotherapy and elevated eosinophil count were associated with increased risk of oxaliplatin HSR, whereas elevated monocyte count and elevated serum albumin were protective factors for the development of oxaliplatin HSR. Conclusion: Colorectal cancer patients treated with an oxaliplatin-based regimen with male gender, prior exposure to platinum-based chemotherapy and elevated eosinophil count have a greater risk of oxaliplatin related hypersensitivity reactions.",
        "prism:coverDate": "2022-04-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85133959611",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Sirinoot",
            "preferred-name": {
                "ce:given-name": "Sirinoot",
                "ce:initials": "S.",
                "ce:surname": "Palapinyo",
                "ce:indexed-name": "Palapinyo S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Palapinyo",
            "@auid": "37031882400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37031882400",
            "ce:indexed-name": "Palapinyo S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85133959611"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133959611&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85133959611&origin=inward"
            }
        ],
        "prism:publicationName": "Pharmacy Practice",
        "source-id": "4700152701",
        "citedby-count": "1",
        "prism:volume": "20",
        "subtype": "ar",
        "dc:title": "Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.18549/PharmPract.2022.2.2635",
        "prism:issn": "18863655 1885642X",
        "publishercopyright": "Â© 2022, Grupo de Investigacion en Atencion Farmaceutica. All rights reserved.",
        "article-number": "2635",
        "dc:identifier": "SCOPUS_ID:85133959611",
        "dc:publisher": "Grupo de Investigacion en Atencion Farmaceutica"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Colorectal cancer"
        },
        {
            "@_fa": "true",
            "$": "Hypersensitivity reactions"
        },
        {
            "@_fa": "true",
            "$": "Oxaliplatin"
        },
        {
            "@_fa": "true",
            "$": "Risk factors"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Sirinoot",
            "preferred-name": {
                "ce:given-name": "Sirinoot",
                "ce:initials": "S.",
                "ce:surname": "Palapinyo",
                "ce:indexed-name": "Palapinyo S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Palapinyo",
            "@auid": "37031882400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37031882400",
            "ce:indexed-name": "Palapinyo S."
        },
        {
            "ce:given-name": "Jettanong",
            "preferred-name": {
                "ce:given-name": "Jettanong",
                "ce:initials": "J.",
                "ce:surname": "Klaewsongkram",
                "ce:indexed-name": "Klaewsongkram J."
            },
            "@seq": "2",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Klaewsongkram",
            "@auid": "6508090526",
            "author-url": "https://api.elsevier.com/content/author/author_id/6508090526",
            "ce:indexed-name": "Klaewsongkram J."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "3",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Nutthada",
            "preferred-name": {
                "ce:given-name": "Nutthada",
                "ce:initials": "N.",
                "ce:surname": "Areepium",
                "ce:indexed-name": "Areepium N."
            },
            "@seq": "4",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Areepium",
            "@auid": "13610558100",
            "author-url": "https://api.elsevier.com/content/author/author_id/13610558100",
            "ce:indexed-name": "Areepium N."
        }
    ]}
}}